Sonavex files Form D for $15 million equity offering
The Baltimore biotech has raised roughly $3.1 million so far from five investors, with over $11.8 million still to be sold.
SEC filing
1 story
The Baltimore biotech has raised roughly $3.1 million so far from five investors, with over $11.8 million still to be sold.
SEC filing